Medical researchers have reported fewer false negatives due to adjunctive use of this AI —
resulting in increased overall prostate cancer diagnostic sensitivity of approximately
7% to 16%. 

— Joe Cummings, Ph.D. 

Vizient technology program
director within Performance Improvement Collaboratives